NEVO DORON 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Apr 29, 2010
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
NEVO DORON
Director
Transactions
- Award
Option to Purchase Common Stock
2010-03-25+168,750→ 168,750 totalExp: 2020-03-25→ Common Stock, par value $0.01 (168,750 underlying)
Footnotes (3)
- [F1]The exercise price is 3.51 NIS per share.
- [F2]The options shall vest in 12 quarterly portions at the end of each calendar quarter commencing March 31, 2010. If the Chairman is removed from his position (except for Cause) during the first year of vesting, a total of 56,250 options shall be vested. If he is removed from his position thereafter (except for Cause), the amount of options vested shall be the amount already vested plus 14,063.
- [F3]The Reporting Person holds an additional 40,000 options to purchase Common Stock at an exercise price of $0.597 each, and an additional 20,000 options to purchase Common Stock at an exercise price of 3.17 NIS each.